
United States Pharmacopoeia (USP) Solutions and Reagents
United States Pharmacopoeia (USP) solutions and reagents are crucial for ensuring the safety, quality, and efficacy of pharmaceuticals in the U.S. market. These products comply with the standards set by the USP and are widely used in drug development and quality control. CymitQuimica offers a comprehensive range of USP-compliant solutions and reagents to support pharmaceutical research and manufacturing.
Found 7624 products of "United States Pharmacopoeia (USP) Solutions and Reagents"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Metaraminol Enantiomer (3-[(1S,2R)-2-Amino-1-hydroxypropyl]phenol D-tartrate)
CAS:Other alkaloids,natural or reproduced by synthesis, and their salts, ethers,esters&other derivatives, nesoiFormula:C9H13NO2C4H6O6Color and Shape:Off-White SolidMolecular weight:167.09463Methylene Blue
CAS:Basic dyes and preparations based thereonFormula:C16H18ClN3S·xH2OColor and Shape:Blue Dark Green CrystalsMolecular weight:319.85 g/molXylometazoline Hydrochloride
CAS:Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormula:C16H24N2·HClColor and Shape:White Off-White PowderMolecular weight:280.17063Acebutolol Related Compound A (N-(3-Acetyl-4-hydroxyphenyl)butyramide)
CAS:Aromatic cyclic amides (including cyclic carbamates) anFormula:C12H15NO3Color and Shape:Light Yellow PowderMolecular weight:221.105192-Chloroadenine (2-Chloro-7H-purin-6-amine)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C5H4ClN5Color and Shape:Off-White White Light Yellow PowderMolecular weight:169.57 g/molZiprasidone Related Compound B (5-{2-[4-(Benzo[d]isothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloroindoline-2,3-dione)
CAS:Compounds containing a benzothiazole ring-system (whether or not hydrogenated), not further fusedFormula:C21H19ClN4O2SColor and Shape:Dark Yellow PowderMolecular weight:426.09172Alitame
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C14H25N3O4S·5H2OColor and Shape:White PowderMolecular weight:331.15658Levofloxacin Related Compound F ((S)-2,3-Dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C18H21N3O4Color and Shape:Off-White Yellow PowderMolecular weight:343.15321Tigecycline
CAS:Tetracyclines and their derivatives; salts thereofFormula:C29H39N5O8Color and Shape:Orange PowderMolecular weight:585.66Lansoprazole Related Compound A (2-({[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl}sulfonyl)benzimidazole)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C16H14F3N3O3SColor and Shape:White Crystalline PowderMolecular weight:385.36Nabumetone
CAS:Ketone-phenols and ketones with other oxygen functionFormula:C15H16O2Color and Shape:PowderMolecular weight:228.11503Betamethasone Valerate Related Compound D (9-Bromo-11β,21-dihydroxy-16β-methyl-3,20-dioxopregna-1,4-dien-17-yl valerate)
CAS:Halogenated derivatives of adrenal cortical hormonesFormula:C27H37BrO6Color and Shape:White Off-White PowderMolecular weight:537.49Ecamsule Related Compound A (1,4-Phenylenedimethanol)
CAS:Aromatic alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives not elsewhere specified or includedFormula:C8H10O2Color and Shape:White Crystalline PowderMolecular weight:138.06808Sodium Metabisulfite
CAS:Sodium sulfitesFormula:Na2S2O5Color and Shape:White PowderMolecular weight:189.89825Diosmin for System Suitability (a mixture of acetoisovanillone, hesperidin, isorhoifolin, diosmin, linarin and diosmetin)
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiColor and Shape:Yellow PowderUracil
CAS:Compounds containing a pyrimidine ring (whether or notFormula:C4H4N2O2Color and Shape:White Off-White PowderMolecular weight:112.09Magnesium Salicylate
CAS:Salicylic acid and its salts suitable for medicinal useFormula:C14H10MgO6·4H2OColor and Shape:PowderMolecular weight:298.03278Sunitinib Amide (5-[(Z)-(5-Fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide)
CAS:Lactams, nesoiFormula:C16H14FN3O2Color and Shape:Pale Yellow Yellow PowderMolecular weight:299.107Estradiol Valerate
CAS:Estrogens and progestinsFormula:C23H32O3Color and Shape:White Crystalline PowderMolecular weight:356.23514Nevirapine Related Compound C (5,11-Dihydro-6H-11-propyl-4-methyl-dipyrido[3,2-b:2',3'-e] [1,4]diazepin-6-one)
Aromatic or modified aromatic drugs with nitrogen hetero-atom(s) only, not elsewhere specified or includedFormula:C15H16N4OColor and Shape:PowderMolecular weight:268.13241Clopidogrel Open Ring R-enantiomer (methyl (R)-2-(2-chlorophenyl)-2-((2-(thiophen-2-yl)ethyl)amino) acetate, hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C15H16ClNO2S·HClColor and Shape:White Off-White SolidMolecular weight:309.05903Stevioside
CAS:Other glycosides, natural or reproduced by synthesis, aFormula:C38H60O18Color and Shape:White PowderMolecular weight:804.88Betaxolol Hydrochloride
CAS:Aromatic drugs of amino-alcohols, other than those contg more than one kind of oxygen function, their ethers and esters; salts thereof, nesoiFormula:C18H29NO3·ClHColor and Shape:White Off-White PowderMolecular weight:343.19142Bexarotene Related Compound A (Methyl 4-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalene-2-carbonyl)benzoate)
CAS:Carboxylic acids with aldehyde or ketone function but without other oxygen function, their anhydrides, halides, peroxides, peroxyacids andtheir derivFormula:C24H28O3Color and Shape:White Off-White SolidMolecular weight:364.49 g/molOlmesartan Medoxomil Related Compound A (1-{[2'-(1H-Tetrazol-5-yl)biphenyl-4-yl]methyl}-4,4-dimethyl-2-propyl-1H-furo[3,4-d]imidazol-6(4H)-one)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C24H24N6O2Color and Shape:White SolidMolecular weight:428.19607Nicotine Related Compound A (1,2,3,6-tetrahydro-2,3'-bipyridine)
CAS:Vegetable alkaloids, natural or reproduced by synthesis, their salts and other derivatives, nesoiFormula:C10H12N2Color and Shape:Pale Yellow Light Brown LiquidMolecular weight:160.10005Ampicillin Sodium
CAS:Ampicillin and its saltsFormula:C16H19N3O4S·NaColor and Shape:White Off-White Crystalline PowderMolecular weight:372.0994Fluoxetine Related Compound C (4-(methyl{3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl}amino)-4-oxobutanoic acid)
Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormula:C21H22F3NO4Color and Shape:PowderMolecular weight:409.41Rivastigmine Related Compound B ((R,S)-3-[1-(Dimethylamino)ethyl]phenyl dimethylcarbamate)
CAS:Aromatic cyclic amides (including cyclic carbamates) anFormula:C13H20N2O2Color and Shape:Yellow LiquidMolecular weight:236.31Simethicone
CAS:Silicones in primary formsFormula:(CH3)3SiOSi(CH3)2nCH3SiO2Color and Shape:Translucent Grey Viscous LiquidMolecular weight:130.2603Flutamide Related Compound B (N-[4-Nitro-3-(trifluoromethyl)phenyl]acetamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormula:C9H7F3N2O3Color and Shape:PowderMolecular weight:248.04088Fluoxetine Hydrochloride
CAS:Aromatic drugs of amino-alcohols, other than those contg > one kind of oxygen function, their ethers and esters; salts thereof, nesoiFormula:C17H18F3NO·HClColor and Shape:White PowderMolecular weight:345.11073Naproxen Related Compound K (1-(6-Methoxynaphthalen-2-yl)ethanol)
CAS:Ether-alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives, nesoiFormula:C13H14O2Color and Shape:White Crystalline PowderMolecular weight:202.25Ibuprofen Related Compound J (2-(4-Isobutyrylphenyl)propanoic acid)
CAS:Aromatic polycarboxylic acids, their anhydrides, halides, peroxides, peroxyacids etc not elsewhere specified or includedFormula:C13H16O3Color and Shape:Brown SolidMolecular weight:220.10994Nadolol Related Compound C
Ether-alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives not elsewhere specified or includedFormula:C23H28O7Color and Shape:Off-White SolidMolecular weight:416.1835Phosphatidylinositol (Soy) Sodium (Sodium 1,2-Diacyl-sn-glycero-3-phospho-D-myo-inositol)
CAS:Non-aromatic phosphoric esters and their salts, including lactophosphates; their halogenated, sulfonated, nitrated or nitrosated derivatives, nesoiFormula:C43H78NaO13PColor and Shape:White PowderMolecular weight:866.65Clopidogrel N-Oxide (5-((S)-1-(2-chlorophenyl)-2-methoxy-2-oxoethyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine 5-oxide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C16H16ClNO3SColor and Shape:Pale Yellow SolidMolecular weight:337.05394Acyclovir Related Compound F (N-[9-[(2-Hydroxyethoxy)methyl]-6-oxo-6,9-dihydro-1H-purin-2-yl]acetamide)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C10H13N5O4Color and Shape:White Yellow Crystalline PowderMolecular weight:267.09675Rifampin
CAS:Antibiotics nesoiFormula:C43H58N4O12Color and Shape:Reddish-Brown PowderMolecular weight:822.40512Daidzein
CAS:Aromatic pesticides with oxygen hetero-atom(s) only neFormula:C15H10O4Color and Shape:White Light Yellow PowderMolecular weight:254.05791Bendroflumethiazide
CAS:Sulfonamides used as drugsFormula:C15H14F3N3O4S2Color and Shape:PowderMolecular weight:421.42Haloperidol Decanoate
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C31H41ClFNO3Color and Shape:White Off-White PowderMolecular weight:529.2759Eptifibatide Dimer
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C70H98N22O18S4Color and Shape:PowderMolecular weight:1662.63123Thiazolylacetyl Glycine Oxime Acetal ((Z)-2-(2-Aminothiazol-4-yl)-N-(2,2-dihydroxyethyl)-2-(hydroxyimino)acetamide)
CAS:Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormula:C7H10N4O4SColor and Shape:Yellow Pale Yellow SolidMolecular weight:246.04228Apixaban Open Ring Amide (6-(4-((5-amino-5-oxopentyl)amino)phenyl)-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide)
CAS:Lactams, nesoiFormula:C25H28N6O4Color and Shape:Light Yellow SolidMolecular weight:476.2172Nimodipine Related Compound B (bis(2-methoxyethyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C21H26N2O8Color and Shape:Pale Yellow Crystalline PowderMolecular weight:434.16892Azathioprine Related Compound A (1-Methyl-4-nitro-1H-imidazol-5-amine)
CAS:Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormula:C4H6N4O2Color and Shape:Yellow PowderMolecular weight:142.12Trazodone Hydrochloride
CAS:Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureFormula:C19H22ClN5O·HClColor and Shape:White Off-White Crystalline PowderMolecular weight:407.12797European Elder Berry Dry Extract
Vegetable saps and extracts, nesoiColor and Shape:Dark Violet Powder

